Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.

Tahedl M, Siah WF, Lope J, Hengeveld JC, Doherty MA, McLaughlin RL, Hardiman O, Tan EL, Toomey A, Kleinerova J, Bede P

Open source

DOI
10.1002/ana.78316
Published
2026 Jul 21
Container
Annals of neurology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ana.78316,
  title = {Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.},
  author = {Tahedl M and Siah WF and Lope J and Hengeveld JC and Doherty MA and McLaughlin RL and Hardiman O and Tan EL and Toomey A and Kleinerova J and Bede P},
  year = {2026},
  journal = {Annals of neurology},
  doi = {10.1002/ana.78316},
  url = {https://doi.org/10.1002/ana.78316}
}

RIS

TY  - JOUR
TI  - Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.
AU  - Tahedl M
AU  - Siah WF
AU  - Lope J
AU  - Hengeveld JC
AU  - Doherty MA
AU  - McLaughlin RL
AU  - Hardiman O
AU  - Tan EL
AU  - Toomey A
AU  - Kleinerova J
AU  - Bede P
PY  - 2026
JO  - Annals of neurology
DO  - 10.1002/ana.78316
UR  - https://doi.org/10.1002/ana.78316
ER  - 

APA

M, T., WF, S., J, L., JC, H., MA, D., RL, M., O, H., EL, T., A, T., J, K., & P, B. (2026). Neurotransmitter-Defined Degeneration Patterns in Sporadic and C9orf72-Associated Amyotrophic Lateral Sclerosis: Predilection to GABAergic, Serotonergic, Opioid, Glutamatergic, Endocannabinoid, and Microglial Systems-Implications for Therapy Development.. Annals of neurology. https://doi.org/10.1002/ana.78316

Source records